Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts

doi:10.12998/wjcc.v12.i36.6950

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 36

This Article

Table of Contents

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2167)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

101

HTML

1438

Sum=1539

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

421

Sum=510

Dec 26, 2024 (publication date) through Mar 3, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correction Open Access

World J Clin Cases. Dec 26, 2024; 12(36): 6950-6951
Published online Dec 26, 2024. doi: 10.12998/wjcc.v12.i36.6950

Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts

This corrects the article "Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts".

Zhen Song, Qi Zhou, Jiang-Lei Zhang, Jun Ouyang, Zhi-Yu Zhang

Zhen Song, Department of Urology, Taixing People’s Hospital, Taizhou 225400, Jiangsu Province, China

Zhen Song, Jiang-Lei Zhang, Jun Ouyang, Zhi-Yu Zhang, Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu Province, China

Qi Zhou, Department of Reproductive Medicine Center, The First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu Province, China

ORCID number: Qi Zhou (0000-0001-6762-4561); Zhi-Yu Zhang (0000-0001-5499-8011).

Co-first authors: Zhen Song and Qi Zhou.

Author contributions: All authors have written, read and approved the final draft.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Corresponding author: Zhi-Yu Zhang, MD, PhD, Doctor, Surgeon, Department of Urology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Gusu District, Suzhou 215000, Jiangsu Province, China. abner_666@126.com

Received: August 8, 2024
Revised: September 30, 2024
Accepted: October 21, 2024
Published online: December 26, 2024
Processing time: 83 Days and 20.7 Hours

Abstract

This is an erratum to the published paper titled “Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts”. We have discovered that Reference 4 was cited incorrectly. We sincerely apologize for this inadvertent error. Please note that these corrections do not impact our results.

Key Words: World Journal of Clinical Cases; Correction

Core Tip: This manuscript is to correct the Reference 4 of "Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024;12(1): 32-41 PMID: 38292624 DOI: 10.12998/wjcc.v12.i1.32".

Citation: Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Correction to: Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024; 12(36): 6950-6951
URL: https://www.wjgnet.com/2307-8960/full/v12/i36/6950.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i36.6950

TO THE EDITOR

In the article[1], the sentence "In China, PCa has surpassed bladder and kidney cancers in terms of incidence and mortality, and is currently the most common tumor in adult urology[4]" incorrectly cites Reference 4 as “Reference 4: Marsh HP, Bowler IC, Watson CJ. Successful treatment of Rhodococcus equi pulmonary infection in a renal transplant recipient. Ann R Coll Surg Engl 2000; 82: 107-108.” The correct Reference 4 should be: “Reference 4: Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, Pan J, Xue W. Prostate cancer treatment - China’s perspective. Cancer Lett 2022; 550: 215927 [PMID: 36162714 DOI: 10.1016/j.canlet.2022.215927]”. Please note that these corrections do not impact our results.

References

Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases. 2024;12:32-41. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 7] [Reference Citation Analysis (7)]

Footnotes

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

P-Reviewer: N/A S-Editor: Li L L-Editor: A P-Editor: Yu HG